STAA
STAA
US8523123052
STAAR Surgical Company
Loading chart...

Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Latest News

Related stocks

KMTS
KMTS • United States
Kestra Medical Technologies, Lt
26.98 USD
1.61B USD 1Y +7.4%
XRAY
XRAY • United States
DENTSPLY SIRONA Inc.
8.83 USD
1.76B USD 1Y -29.8%
AZTA
AZTA • United States
Azenta, Inc.
37.72 USD
1.65B USD 1Y +11.7%
ATRC
ATRC • United States
AtriCure, Inc.
55.81 USD
2.84B USD 1Y +50.6%
BLFS
BLFS • United States
BioLife Solutions, Inc.
38.61 USD
1.89B USD
LMAT
LMAT • United States
LeMaitre Vascular, Inc.
80.69 USD
1.85B USD 1Y -9.5%
MMED
MMED • United States
MiniMed Group, Inc.
19.71 USD
5.55B USD
NVST
NVST • United States
Envista Holdings Corporation
23 USD
3.69B USD 1Y +10.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
61.6% p.a.
Max Drawdown (5Y)
-88.0%
Sharpe Ratio (5Y)
-0.50
Beta Factor
1.18
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 270.9 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (61.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -90.7% in the extended horizon.
ende